NASDAQ:APHA Aphria (APHA) Stock Price, News & Analysis → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free APHA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$15.38▼$15.3850-Day Range$13.14▼$18.3752-Week Range$2.78▼$32.29VolumeN/AAverage Volume21.83 million shsMarket Capitalization$4.87 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Aphria alerts: Email Address Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. About Aphria Stock (NASDAQ:APHA)Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.Read More Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. APHA Stock News HeadlinesSeptember 27, 2023 | benzinga.comSheep Ate 600lbs Of Cannabis While Sheltering From A Storm: Here's What They Did NextSeptember 25, 2023 | markets.businessinsider.comEwe Won't Believe It: Greek Sheep's 'Highly' Unconventional Cannabis Greenhouse AdventureApril 25, 2024 | Stansberry Research (Ad)World’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.June 8, 2023 | markets.businessinsider.comTilray CFO Engages Shareholders On Reddit, Addresses Concerns And Company's Growth StrategyJanuary 3, 2023 | nypost.comHow to bet on Horse Racing: Complete guide to Horse Betting OnlineOctober 14, 2022 | fool.comWhy Owens & Minor Shares Plummeted 32.4% This Week - The Motley FoolOctober 11, 2022 | prnewswire.comThe Continued Legalization of Cannabis Creates Need for Intoxication Detection Devices - PR NewswireOctober 10, 2022 | finance.yahoo.comIndustrial hemp Market Size-2022 Will Revenue to Cross readjusted size of US$ 3259.5 million by 2028 Top Companies report covers, (It was also one of the primary plants to be rolled into usable fibre 50,000 years ago.) - Yahoo FinanceApril 25, 2024 | Stansberry Research (Ad)World’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.October 8, 2022 | seekingalpha.comTilray Brands Stock: Pot Pops Then Drops - Seeking AlphaOctober 7, 2022 | law360.comJPay Founder Says Insider Trading Case Falls Short - Law360October 4, 2022 | businesswire.comGlobal Medical Marijuana Market Trends/Analysis Report 2022: A $65.8 Billion Industry by 2030 - Rapid Adoption of Cannabis in Therapeutic Applications - ResearchAndMarkets.com - Business WireOctober 1, 2022 | prnewswire.comGlobal Cannabis Extract Market to Reach $15.5 Billion by 2030 at a CAGR of 20.6% - PR NewswireSeptember 28, 2022 | businesswire.comGlobal Legal Cannabis Market Size, Trends & Analysis Report 2022-2030: Regulatory Scenario, Consumption Pattern, Potential Trade Opportunities, Case Studies, End-users, Competitive Landscape - ResearchAndMarkets.com - Business WireSeptember 27, 2022 | globenewswire.comCannabis Beverages Market to Reach USD 19,063.58 Million by - GlobeNewswireSeptember 26, 2022 | finance.yahoo.comGlobal Legal Cannabis Market Analysis Report 2022: A $134.4 Billion Industry by 2030, Growing at a CAGR of Over 25% - Yahoo FinanceSeptember 17, 2022 | seekingalpha.comTLRY Tilray Brands, Inc.September 14, 2022 | globenewswire.comWith 27.5% CAGR, Global CBD-Infused Beverages Market Size - GlobeNewswireSeptember 13, 2022 | prnewswire.comYourWay Cannabis Brands Provides Corporate Update - PR NewswireSeptember 13, 2022 | businesswire.comMorganti & Co., Announces that Class Certification Scheduled in the pending shareholder litigation against Auxly Cannabis Group, Inc. - Business WireSeptember 11, 2022 | benzinga.comJoana ScopelSeptember 10, 2022 | benzinga.comTilray Brands (NASDAQ:TLRY) – A Shareholder Lawsuit Stemming From Aphria Could Expose Tilray—Trouble In C - BenzingaSeptember 7, 2022 | investors.comIs TLRY Stock A Buy As Germany Gets Closer To Cannabis Legalization? - Investor's Business DailySeptember 2, 2022 | seekingalpha.comTLRY stock gains after debt agreement with JV partner (NASDAQ:TLRY) - Seeking AlphaSeptember 1, 2022 | law360.comCanadian Pot Co. Investors Win Class Cert. In Acquisition Suit - Law360August 31, 2022 | globenewswire.comIndustrial Hemp Market Worth USD 3259.5 million by 2028 | Growth, Size, Shares, Revenue, Types, Applications, Key Players, Top Countries, Growing Factors, Key Dynamics - GlobeNewswireAugust 25, 2022 | finance.yahoo.comTilray Medical Launches New Products and ‘CannaPoints’ Program to Support Patients Across Canada - Yahoo FinanceSee More Headlines Receive APHA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aphria and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/11/2021Today4/25/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medicinals & Botanicals Sub-IndustryN/A Current SymbolNASDAQ:APHA CUSIPN/A CIKN/A Webaphriainc.com Phone(844) 427-4742FaxN/AEmployees1,200Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-63,210,000.00 Net Margins-36.10% Pretax MarginN/A Return on Equity-2.30% Return on Assets-1.66% Debt Debt-to-Equity Ratio0.25 Current Ratio2.36 Quick Ratio1.17 Sales & Book Value Annual Sales$405.96 million Price / Sales12.00 Cash Flow$0.09 per share Price / Cash Flow166.43 Book Value$4.80 per share Price / Book3.20Miscellaneous Outstanding Shares316,795,000Free FloatN/AMarket Cap$4.87 billion OptionableOptionable Beta2.67 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Irwin D. Simon (Age 62)CEO & Chairman Comp: $5.23MMr. Carl A. MertonChief Financial OfficerDr. Christelle Gedeon L.L.B.Ph.D., Chief Legal Officer & Corp. Sec.Mr. James R. MeiersChief Operating Officer of Aphria LeamingtonMs. Denise Menikheim Faltischek (Age 48)Chief Strategy Officer & MD of Aphria Germany Comp: $449.68kMr. John B. SadlerVP of Investor RelationsMr. Bernard YeungSr. VP of Sales & MarketingMr. Victor Neufeld (Age 67)Special Advisor Mr. Cole Cacciavillani (Age 66)Special Advisor Mr. Randy DaigneauSr. VP of Supply ChainMore ExecutivesKey CompetitorsHalozyme TherapeuticsNASDAQ:HALOCRISPR TherapeuticsNASDAQ:CRSPOrganon & Co.NYSE:OGNGlaukosNYSE:GKOSKrystal BiotechNASDAQ:KRYSView All Competitors APHA Stock Analysis - Frequently Asked Questions How were Aphria's earnings last quarter? Aphria Inc. (NASDAQ:APHA) announced its quarterly earnings data on Sunday, April, 11th. The company reported ($1.14) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.04) by $1.10. The company had revenue of $153.60 million for the quarter, compared to the consensus estimate of $172.01 million. Aphria had a negative net margin of 36.10% and a negative trailing twelve-month return on equity of 2.30%. The company's revenue was up 6.4% compared to the same quarter last year. During the same quarter last year, the firm posted $0.02 earnings per share. Read the conference call transcript. What other stocks do shareholders of Aphria own? Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include AbbVie (ABBV), Alibaba Group (BABA), Mastercard (MA), Block (SQ), Abbott Laboratories (ABT), Alteryx (AYX), Big Lots (BIG) and BlackRock (BLK). This page (NASDAQ:APHA) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aphria Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
